Penny Ng

Penny Ng is a seasoned professional in regulatory affairs with extensive experience in the pharmaceutical industry. Currently serving as Vice President of Regulatory Affairs at Merus N.V. since April 2022, Penny has held key positions in prominent companies including Bristol Myers Squibb and Celgene, focusing on global regulatory strategies in inflammation, immunology, and hematology/oncology. Penny's educational background is robust, featuring a Doctorate and Master’s degree in Regulatory Science from the University of Southern California, coupled with a Master’s in Regulatory Affairs from San Diego State University, an MBA in Finance from York University, and a Bachelor’s in Microbiology from the University of Toronto.